Resources

Whitepapers

Our Approach to Protecting Patient Privacy

Advancing cardiovascular research

Cardiovascular disease is a leading cause of death in the US, but researchers face many challenges when seeking to study the safety and effectiveness of drugs and devices used to treat it. This whitepaper highlights historical limitations of RWD and explains how Truveta addresses them to accelerate research on outcomes and care.

Our Approach to Protecting Patient Privacy

Patient privacy

Founded by health systems, Truveta has a deep commitment to patient privacy. This whitepaper shares details of Truveta’s advanced de-identification process and how identifiers in Truveta Data are managed and protected according to HIPAA standards.

Truveta whitepaper Our Approach to Data Security report cover

Data security

 Our security systems protect data through every stage of the data process and have been validated to meet the most rigorous standards for security and privacy. This paper focuses on how we store and secure Truveta Data.

Our Approach to Protecting Patient Privacy

Data quality

Truveta Data comprises billions of EHR data points, representing ~100 million patient journeys from more than 20,000 clinics and 800 hospitals, updated daily. Truveta Data is held to the highest standards of data quality and provenance, with a rigorous quality control process, outlined in this whitepaper.

 

Whitepaper cover: Our Approach to Data Analytics Fall 2022

Data analytics

Truveta Studio delivers fast, convenient analytics, empowering everyone on the team to learn from Truveta Data. Learn more about Truveta Studio and how it empowers researchers with powerful insights to improve patient outcomes, accelerate R&D, and inform public policy.

Whitepaper cover: Our Approach to Data Analytics Fall 2022

Truveta Language Model

This whitepaper introduces the Truveta Language Model, a large-language, multi-modal AI model used to clean billions of daily EHR data points for health research. TLM’s healthcare expertise is trained on the largest collection of complete medical records, representing the full diversity of the US. It is the first large-language model specifically designed to empower researchers to study all patient care and outcomes.   

Whitepaper cover: Our Approach to Data Analytics Fall 2022

Better device outcomes through better data

Medical device companies are challenged by a significant lack of real-world data on device use in clinical practice. In this whitepaper, learn how Truveta provides critical device specific information linked to deep clinical data to accelerate device research for over 150,000 unique medical devices.

Whitepaper cover: Our Approach to Data Analytics Fall 2022

Ethics policy

We believe it is a moral imperative to harness the power of data to improve healthcare. We know we’ve taken on an enormous responsibility, and we pursue our work with a commitment to patient privacy, broadly enabling research and transparency about our data, all in close coordination with our member health systems.

Research & Publications

Truveta whitepaper Our Approach to Data Security report cover

eBook: COVID-19 insights part I

The Truveta Research team spent almost a year digging into the data to inform insights and studies to better understand health across our de-identified population with a focus on those affected by COVID-19 and the effects of the pandemic.

Truveta whitepaper Our Approach to Data Security report cover

eBook: COVID-19 insights part II

After our initial analyses in the COVID-19 Insights eBook Part I, we were curious to dive further in the data to uncover any disparities in COVID-19 hospitalizations across the different waves of the pandemic.  A benefit of Truveta Studio is the ability to ask and answer unlimited questions of these data.  

Truveta whitepaper Our Approach to Data Security report cover

eBook: Peripheral artery disease treatment and outcomes

Peripheral Artery Disease (PAD) is a common disease that causes the narrowing of the arteries in the extremities. As part of PAD Awareness month, Truveta Research investigated disparities in the frequency of common procedures used to treat PAD, known as endovascular (or minimally invasive) revascularization, and the associated outcomes.

Truveta whitepaper Our Approach to Data Security report cover

One-pager: Disparities in COVID-19 hospitalizations

COVID-19 impacted communities disproportionately. Especially in the early days of the pandemic, countless reports of inequitable access to treatments and treatment pathways brought to light existing and new disparities in health outcomes.

Truveta whitepaper Our Approach to Data Security report cover

One-pager: Long COVID & mental health

Some diagnosed with COVID-19 have a variety of post-COVID-19 symptoms, commonly referred to as long COVID-19. Given the potential dire outcomes from mental health disorders, it is important to understand mental health outcomes as the effects of long COVID-19 are becoming apparent.

Truveta whitepaper Our Approach to Data Security report cover

One-pager: Who is getting long COVID?

The risk factors for developing long COVID-19 are still being studied in the United States and worldwide. We conducted independent research using a subset of Truveta data to learn more long COVID-19.

Truveta whitepaper Our Approach to Data Security report cover

Publication: Truveta Mapper: A zero-shot ontology alignment framework

We share the technical details behind Truveta Mapper the underlying AI technology in the Truveta Language Model. Truveta Mapper leverages a multi-task sequence-to-sequence transformer model to perform alignment across multiple ontologies in a zero-shot, unified, and end-to-end manner. This paper was originally published at arXiv.

Videos

Terry Myerson Truveta CEO introduces the Truveta Platform

Introducing Truveta Studio: Delivering the Health Data and Analytics the World Deserves Now

Terry Myerson Truveta CEO introduces the Truveta Platform

Truveta Announces Collaboration with Boston Scientific

Terry Myerson Truveta CEO introduces the Truveta Platform

Empowering Researchers with Truveta Studio

An image of all of the Truveta health system members' logos

Health System leaders form Truveta to save lives with data

Terry Myerson Truveta CEO introduces the Truveta Platform

Helping Address Health Inequities with Data

Terry Myerson Truveta CEO introduces the Truveta Platform

The Importance of Data Quality for Medical Research

An image of all of the Truveta health system members' logos

Truveta and LexisNexis Risk Solutions Partner to Improve Data Quality and Health Equity

Terry Myerson Truveta CEO introduces the Truveta Platform

Introducing the Truveta Platform and New COVID-19 Insights

Terry Myerson Truveta CEO introduces the Truveta Platform

Microsoft and Truveta Announce Strategic Partnership to Achieve Our Vision of Saving Lives with Data

Events on-demand

Webinar: Advancing clinical research through unprecedented data and learning community for health

Partnering with Fierce Pharma, hear from an expert panel on the power of unprecedented data and what early patient insights have been unveiled.

Keynote: Terry Myerson at ViVE 2022

Watch Truveta CEO Terry Myerson share Truveta’s origin story, explain why Truveta is so different from its competitors in the healthcare data space, and call for more health systems in the United States to join Truveta in its vision of saving lives with data.

Featured research insight

Disparities in COVID-19 hospitalizations: from insights to pre-print

Many researchers have goals to conduct novel science, uncover new trends, report findings that increase knowledge on a given topic, and push the field forward. To accomplish…